Medrio delivers integrated eClinical software designed specifically for the needs of researchers conducting early phase pharma, medical device, and diagnostics clinical trials. Success is defined by helping customers’ to accelerate their research, eliminate hurdles, and maximize their return on investment. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more.
Medrio is a market leader in early phase trials and serves more than 600 customers globally, with headquarters in San Francisco and offices across the United States, Europe, and Asia. Customers include several of the top Clinical Research Organizations (CRO) and clinical trial sponsors in biopharma, diagnostics, and more.